|
PRA Guidance statement Repurposed Anti-Rheumatic Drugs for the Treatment of Cytokine Storm Syndrome Secondary to Covid-19 Pneumonia
|
Sep. 20, 2021 |
|
PCCP and PCP Joint Statement Hydrogen Peroxide
|
Sep. 17, 2021 |
|
PSMID Statement of Solidarity with Frontline COVID-19 Health Providers
|
May. 11, 2021 |
|
Joint Statements of the Philippine Heart Association (PHA) and the Philippine Society of hypertension (PSH) on Elevated Blood Pressure Readings During Covid Vaccination
|
Mar. 21, 2021 |
|
Position Statements of the PSAAI on COVID Vaccines and their adverse-reactions
|
Mar. 21, 2021 |
|
Position Statements of the Philippine Society of Allergy, Asthma, and Immunology On COVID-19 Vaccines and their Adverse Reactions
|
Feb. 26, 2021 |
|
COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD)
|
Feb. 26, 2021 |
|
PSG Position Statement on Performing Endoscopic Procedures During the COVID-19 Pandemic
|
Jun. 15, 2020 |
|
PCCP Statements on the Performance of Bronchoscopy During the COVID-19 Pandemic
|
Jun. 15, 2020 |
|
PCHTM Position Statement on the Use of Convalescent Plasma
|
Jun. 15, 2020 |
